{"id":3987,"name":"Deep Control Capital","slug":"deep-control-capital","website":null,"hqGeo":"London, UK","stageFocus":["Series A"],"sectorTags":["Other","Enterprise"],"excludedSectors":["Consumer","EdTech"],"checkSizeMin":750000,"checkSizeMax":5000000,"thesisSummary":"Deep Control Capital specializes in companies creating control systems for autonomous and ultra-automated enterprises, particularly in regulated industries.","thesisNarrative":null,"logoUrl":null,"aumUsd":48000000,"submissionUrl":null,"linkedinUrl":null,"twitterHandle":null,"portfolio":[{"companyName":"NeuroGate","companyUrl":null,"stage":null,"sector":"AI Safety","investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null}],"partnerCount":6,"partners":[{"id":3722,"name":"Emma Clarkson","title":"Founder GP","seniority":null,"focusTags":["AI Governance","Enterprise Platforms"],"linkedinUrl":null,"twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":17954,"name":"David Kroin","title":"General Partner","seniority":null,"focusTags":["Biotechnology","Life Sciences","Public / Pre-IPO biotech companies"],"linkedinUrl":"https://www.linkedin.com/in/david-kroin-9a562924","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":17955,"name":"Brett Erkman","title":"Managing Partner","seniority":null,"focusTags":["Healthcare Finance","Biotech Investing","Public / Private Transition"],"linkedinUrl":null,"twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":17956,"name":"Rebecca Luse","title":"Managing Partner","seniority":null,"focusTags":["Crossover / Public Company Strategy","Specialty Pharmaceuticals","Biotech"],"linkedinUrl":null,"twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":17957,"name":"Rael Mazansky, MD/MBA","title":"Managing Partner","seniority":null,"focusTags":["Therapeutics","Gene-Therapy / Oncology / Immunology","Clinical Development"],"linkedinUrl":"https://www.linkedin.com/in/raelmazansky","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":17958,"name":"Gerard Smith, MD/MBA","title":"Managing Partner","seniority":null,"focusTags":["Cell & Gene Therapy","CNS / Rare Diseases","Public Biotech"],"linkedinUrl":"https://www.linkedin.com/in/gerard-smith-md-mba-1b1b1b1b","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]}],"funds":[],"activity":{"lastInvestmentYear":null,"investmentsLast12Months":0},"investorType":"vc","preferredApproach":"cold outreach ok","prefersFounderType":null,"oneClickPitchEnabled":false,"relatedFirms":[{"id":3979,"name":"SafeSystems VC","slug":"safesystems-vc","logoUrl":null,"website":"http://www.safesystems.com/","stageFocus":["Seed"],"sectorTags":["Other","SaaS","AI / ML","Enterprise","Developer Tools","Security"],"hqGeo":"Berlin, Germany"},{"id":9586,"name":"NextGen Ventures","slug":"nextgen-ventures","logoUrl":null,"website":"https://nextgenvp.com/","stageFocus":["Pre-Seed","Seed"],"sectorTags":["Other","Enterprise","SaaS"],"hqGeo":"Austin, TX"},{"id":12043,"name":"Digital Growth Fund","slug":"digital-growth-fund","logoUrl":null,"website":"https://digitalgrowthfund.com/","stageFocus":["Pre-Seed","Seed"],"sectorTags":["SaaS","AI / ML","Enterprise","Other"],"hqGeo":"Toronto, Canada"},{"id":3344,"name":"Small Step Ventures","slug":"small-step-ventures","logoUrl":null,"website":null,"stageFocus":["Seed"],"sectorTags":["Other","SaaS","Enterprise"],"hqGeo":"Austin, TX"},{"id":385,"name":"Tola Capital","slug":"tola-capital","logoUrl":null,"website":"https://tolacapital.com/","stageFocus":["Series A","Seed"],"sectorTags":["Enterprise","SaaS","Other","Security"],"hqGeo":"Seattle, WA"},{"id":10628,"name":"Founder's Framework","slug":"founder-s-framework","logoUrl":null,"website":"https://www.foundersframeworks.com/","stageFocus":["Pre-Seed"],"sectorTags":["SaaS","Enterprise"],"hqGeo":"Los Angeles, CA"}],"featuredIn":[{"slug":"series-a","displayName":"Series A Investors","pageType":"stage"}],"fundraisingResources":[{"slug":"how-many-investors-should-you-pitch","title":"How Many Investors Should You Pitch? The Math Most Founders Get Wrong"},{"slug":"what-vcs-actually-look-for-pitch-deck","title":"What VCs Actually Look for in a Pitch Deck"},{"slug":"find-right-pre-seed-investors-b2b-saas","title":"How to Find the Right Pre-Seed Investors for Your B2B SaaS Startup"}],"overviewNarrative":null,"portfolioNarrative":null,"seoTitle":null,"seoDescription":null,"lastVerifiedAt":"2026-07-17T20:50:51.186Z"}